Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Clinical trial NCT05429502 · TERMINATED
Trial details
- NCT number
- NCT05429502
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-27
- Primary completion
- 2025-02-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.